These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 11396274)

  • 21. Facial onset sensory motor neuronopathy (FOSMN) syndrome: an unusual amyotrophic lateral sclerosis phenotype?
    Vucic S
    J Neurol Neurosurg Psychiatry; 2014 Sep; 85(9):951. PubMed ID: 24643461
    [No Abstract]   [Full Text] [Related]  

  • 22. Basic fibroblast growth factor does not prolong survival in a transgenic model of familial amyotrophic lateral sclerosis.
    Upton-Rice MN; Cudkowicz ME; Warren L; Mathew RK; Ren JM; Finklestein SP; Brown RH
    Ann Neurol; 1999 Dec; 46(6):934. PubMed ID: 10589551
    [No Abstract]   [Full Text] [Related]  

  • 23. Depletion of reduced glutathione enhances motor neuron degeneration in vitro and in vivo.
    Chi L; Ke Y; Luo C; Gozal D; Liu R
    Neuroscience; 2007 Feb; 144(3):991-1003. PubMed ID: 17150307
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HoxB2 binds mutant SOD1 and is altered in transgenic model of ALS.
    Zhai J; Lin H; Canete-Soler R; Schlaepfer WW
    Hum Mol Genet; 2005 Sep; 14(18):2629-40. PubMed ID: 16079151
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutation of superoxide dismutase elevates reactive species: comparison of nitration and oxidation of proteins in different brain regions of transgenic mice with amyotrophic lateral sclerosis.
    Liu D; Bao F; Wen J; Liu J
    Neuroscience; 2007 Apr; 146(1):255-64. PubMed ID: 17368952
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Calcineurin activity is regulated both by redox compounds and by mutant familial amyotrophic lateral sclerosis-superoxide dismutase.
    Ferri A; Gabbianelli R; Casciati A; Paolucci E; Rotilio G; Carrì MT
    J Neurochem; 2000 Aug; 75(2):606-13. PubMed ID: 10899935
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Familial amyotrophic lateral sclerosis and mutations in the Cu/Zn superoxide dismutase gene].
    Nakano R
    Rinsho Shinkeigaku; 1995 Dec; 35(12):1546-8. PubMed ID: 8752459
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Slowing of axonal transport is a very early event in the toxicity of ALS-linked SOD1 mutants to motor neurons.
    Williamson TL; Cleveland DW
    Nat Neurosci; 1999 Jan; 2(1):50-6. PubMed ID: 10195180
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Brachial amyotrophic diplegia associated with a novel SOD1 mutation (L106P).
    Valentino P; Conforti FL; Pirritano D; Nisticò R; Mazzei R; Patitucci A; Sprovieri T; Gabriele AL; Muglia M; Clodomiro A; Gambardella A; Zappia M; Quattrone A
    Neurology; 2005 Apr; 64(8):1477-8. PubMed ID: 15851752
    [No Abstract]   [Full Text] [Related]  

  • 30. Increased production of reactive oxygen species contributes to motor neuron death in a compression mouse model of spinal cord injury.
    Xu W; Chi L; Xu R; Ke Y; Luo C; Cai J; Qiu M; Gozal D; Liu R
    Spinal Cord; 2005 Apr; 43(4):204-13. PubMed ID: 15520836
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice.
    Clement AM; Nguyen MD; Roberts EA; Garcia ML; Boillée S; Rule M; McMahon AP; Doucette W; Siwek D; Ferrante RJ; Brown RH; Julien JP; Goldstein LS; Cleveland DW
    Science; 2003 Oct; 302(5642):113-7. PubMed ID: 14526083
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extension of Drosophila lifespan by overexpression of human SOD1 in motorneurons.
    Parkes TL; Elia AJ; Dickinson D; Hilliker AJ; Phillips JP; Boulianne GL
    Nat Genet; 1998 Jun; 19(2):171-4. PubMed ID: 9620775
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Genetics of motor neuron disorders].
    Corcia P; Praline J; Vourc'h P; Andres C
    Rev Neurol (Paris); 2008 Feb; 164(2):115-30. PubMed ID: 18358870
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Age at onset in sod1-mediated amyotrophic lateral sclerosis shows familiality.
    Fogh I; Rijsdijk F; Andersen PM; Sham PC; Knight J; Neale B; McKenna-Yasek D; Silani V; Brown RH; Powell JF; Al-Chalabi A
    Neurogenetics; 2007 Aug; 8(3):235-6. PubMed ID: 17549529
    [No Abstract]   [Full Text] [Related]  

  • 35. Of mice, men and motor neurons.
    Newbery HJ; Abbott CM
    Trends Genet; 2001 Oct; 17(10):S2-6. PubMed ID: 11585669
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The genetic and molecular mechanisms of motor neuron disease.
    Wong PC; Rothstein JD; Price DL
    Curr Opin Neurobiol; 1998 Dec; 8(6):791-9. PubMed ID: 9914243
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tetracycline-regulated gene expression in the NSC-34-tTA cell line for investigation of motor neuron diseases.
    Babetto E; Mangolini A; Rizzardini M; Lupi M; Conforti L; Rusmini P; Poletti A; Cantoni L
    Brain Res Mol Brain Res; 2005 Oct; 140(1-2):63-72. PubMed ID: 16125275
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Motor neuron disease and ubiquitin-proteasome system dysfunction].
    Niwa J; Sobue G
    Tanpakushitsu Kakusan Koso; 2006 Aug; 51(10 Suppl):1423-7. PubMed ID: 16922412
    [No Abstract]   [Full Text] [Related]  

  • 39. Recent MUNE studies in animal models of motor neuron disease.
    Shefner JM
    Suppl Clin Neurophysiol; 2009; 60():203-8. PubMed ID: 20715383
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Current conceptions on etiology, pathogenesis and treatment of motor neuron disease].
    Skvortsova VI; Limborskaia SA; Levitskiĭ GN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2005; 105(1):4-12. PubMed ID: 15704476
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.